Kura Oncology, Inc. (KURA)
8.46
-0.12
(-1.40%)
USD |
NASDAQ |
Feb 20, 16:00
8.455
0.00 (0.00%)
Pre-Market: 20:00
Kura Oncology EPS Diluted (Quarterly) : -0.8456 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.12M |
| Revenue (Quarterly) | 20.75M |
| Total Expenses (Quarterly) | 94.87M |
| Enterprise Value | 205.97M |
| Gross Profit Margin (Quarterly) | 99.21% |
| Profit Margin (Quarterly) | -357.2% |
| Earnings Yield | -29.29% |
| Normalized Earnings Yield | -29.29 |